Paroxetine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Paroxetine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed buprenorphine (a pain or opioid-dependence medicine) and paroxetine (Paxil, an antidepressant). Taking them together can add up in a few ways. Both can affect the heart's rhythm (called QT prolongation), and both raise serotonin, a brain chemical. Too much serotonin can cause a reaction called serotonin syndrome, with symptoms like shakiness, fast heartbeat, sweating, agitation, or confusion. Both can also slow the gut, which may lead to severe constipation.
This concern is mostly theoretical, but it's worth taking seriously. The good news is your care team can manage this safely by watching you closely, especially when you start or change doses. Please don't stop either medicine on your own.
Additive risk when combining buprenorphine and paroxetine:
- QT prolongation: both agents can prolong the QT interval (paroxetine weakly); additive effect raises torsades risk.
- Serotonin syndrome: paroxetine is a potent SSRI; buprenorphine has serotonergic activity. Additive serotonergic tone increases risk.
- Paralytic ileus: additive reduction in GI motility (opioid plus anticholinergic/serotonergic effects).
Evidence: theoretical. Severity: major. Onset: unspecified. Neither is a prodrug relevant here; this is a pharmacodynamic (additive), not PK, interaction. Management: avoid if possible. If unavoidable, monitor at initiation and dose changes for serotonin syndrome (autonomic, neuromuscular, mental-status changes), watch for severe constipation, and consider ECG/electrolyte monitoring. Discontinue if serotonin syndrome suspected.
What happens
An increased risk of QT interval prolongation, an increased risk of serotonin syndrome and an increased risk of paralytic ileus
Interaction Deep Dive
Do not combine buprenorphine with medications capable of prolonging the QT interval34. Furthermore, using buprenorphine together with other drugs that influence the serotonergic neurotransmitter system can raise the likelihood of serotonin syndrome. When such combined use cannot be avoided, monitor the patient, particularly when starting therapy and when adjusting the dose, and stop treatment if serotonin syndrome is suspected. Watch for indications of severe constipation, as this may lead to paralytic ileus 21.
Why it happens (mechanism)
Additive QT interval prolongation; additive serotonergic effects; additive effects on gastric motility
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Your care team can manage this combination by watching you more closely, especially when starting either drug or adjusting a dose.
- Tell your team right away if you notice agitation, confusion, fast heartbeat, heavy sweating, shivering, muscle twitching, or tremor (possible serotonin syndrome).
- Report severe constipation or belly pain, bloating, and vomiting, which could signal the gut slowing too much.
- Your team may check your heart rhythm (ECG) and choose whether an alternative medicine is a better fit.
Bring up any dizziness or fainting with your pharmacist or doctor.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Paroxetine and Buprenorphine together?
Combining buprenorphine and paroxetine can add up to raise the risk of heart-rhythm changes, serotonin syndrome, and severe constipation, so your care team should monitor you closely, especially at start or dose changes. Report symptoms promptly and never stop either medicine on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Paroxetine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Paroxetine and Buprenorphine interaction managed?
Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Your care team can manage this combination by watching you more closely, especially when starting either drug or adjusting a dose. Tell your team right away if you notice agitation, confusion, fast heartbeat, heavy sweating, shivering, muscle twitching, or tremor (possible serotonin syndrome). Report sever… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Paroxetine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Paroxetine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist